Alnylam Pharmaceuticals Revenue 2010-2024 | ALNY

Alnylam Pharmaceuticals revenue for the twelve months ending September 30, 2024 was $2.095B, a 21.54% increase year-over-year.

  • Alnylam Pharmaceuticals annual revenue for 2023 was $1.828B, a 76.23% increase from 2022.
  • Alnylam Pharmaceuticals annual revenue for 2022 was $1.037B, a 22.88% increase from 2021.
  • Alnylam Pharmaceuticals annual revenue for 2021 was $0.844B, a 71.31% increase from 2020.

Alnylam Pharmaceuticals Revenue 2010-2024 | ALNY

  • Alnylam Pharmaceuticals annual revenue for 2023 was $1.828B, a 76.23% increase from 2022.
  • Alnylam Pharmaceuticals annual revenue for 2022 was $1.037B, a 22.88% increase from 2021.
  • Alnylam Pharmaceuticals annual revenue for 2021 was $0.844B, a 71.31% increase from 2020.